Suppr超能文献

胰高血糖素通过其自身受体刺激大鼠胰岛素分泌的证据。

Evidence that glucagon stimulates insulin secretion through its own receptor in rats.

作者信息

Kawai K, Yokota C, Ohashi S, Watanabe Y, Yamashita K

机构信息

Department of Internal Medicine, University of Tsukuba, Japan.

出版信息

Diabetologia. 1995 Mar;38(3):274-6. doi: 10.1007/BF00400630.

Abstract

Since glucagon-like peptide-1 (7-36) amide (7-37) (GLP-1) has been found to be a potent insulinotropic hormone, it has been postulated that glucagon stimulates insulin secretion from islet beta cells through the GLP-1 receptor. We therefore examined the effects of a GLP-1 receptor antagonist, exendin (9-39) amide, on glucagon- or GLP-1-stimulated insulin release from isolated perfused rat pancreas. When infusion of 100 nmol/l exendin (9-39) amide was started 5 min before that of 1 nmol/l glucagon, the stimulation of insulin release by glucagon was similar to that found in the control situation (preinfusion with vehicle alone). By contrast, when 0.3 nmol/l GLP-1 was used in the same experimental setting, exendin (9-39) amide clearly inhibited insulin release. These results indicate that glucagon stimulates insulin release mainly through glucagon receptors but not GLP-1 receptors on islet beta cells.

摘要

由于已发现胰高血糖素样肽-1(7-36)酰胺(7-37)(GLP-1)是一种强效促胰岛素分泌激素,因此有人推测胰高血糖素通过GLP-1受体刺激胰岛β细胞分泌胰岛素。因此,我们研究了GLP-1受体拮抗剂艾塞那肽(9-39)酰胺对胰高血糖素或GLP-1刺激的离体灌注大鼠胰腺胰岛素释放的影响。当在输注1 nmol/l胰高血糖素前5分钟开始输注100 nmol/l艾塞那肽(9-39)酰胺时,胰高血糖素对胰岛素释放的刺激作用与对照情况(仅用载体预灌注)相似。相比之下,当在相同实验设置中使用0.3 nmol/l GLP-1时,艾塞那肽(9-39)酰胺明显抑制胰岛素释放。这些结果表明,胰高血糖素主要通过胰岛β细胞上的胰高血糖素受体而非GLP-1受体刺激胰岛素释放。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验